2-{[2-formyl-4-(trifluoromethyl)phenyl](methyl)amino}acetic acid

Catalog No. :
ACWBUE581
CAS No. :
953062-31-2
Molecular Formula :
C11H10F3NO3
Molecular Weight :
261.20

IUPAC Name:N-(2-formyl-4-(trifluoromethyl)phenyl)-N-methylglycine

2-{[2-formyl-4-(trifluoromethyl)phenyl](methyl)amino}acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$51.00Login to see priceIn stockInquiry
250mg95%$73.00Login to see priceIn stockInquiry
1g95%$171.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-{[2-formyl-4-(trifluoromethyl)phenyl](methyl)amino}acetic acid
IUPAC NameN-(2-formyl-4-(trifluoromethyl)phenyl)-N-methylglycine
MDL No.MFCD21602457
Molecular FormulaC11H10F3NO3
Molecular Weight261.20
SMILESO=C(O)CN(C1=CC=C(C(F)(F)F)C=C1C=O)C
InChI KeyCYOITVYIQFZMNI-UHFFFAOYSA-N
SynonymGlycine, N-[2-formyl-4-(trifluoromethyl)phenyl]-N-methyl-;2-{[2-Formyl-4-(trifluoromethyl)phenyl](methyl)amino}acetic Acid
CAS No.953062-31-2
PubChem CID73994636

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWBUE581 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBCZY547 route compound structure diagram
    ACBCZY547637-96-7 In Stock
  2. Plus
  3. ACKSBM120 route compound structure diagram
    ACKSBM120146137-78-2 In Stock
  4. Then
  5. ACWBUE581 route product structure diagram
    ACWBUE581953062-31-2 In Stock
Inquiry

2. ACWBUE581 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWBUE581 route product structure diagram
    ACWBUE581953062-31-2 In Stock
Inquiry

Comments (0)